# Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

> **NCT07125729** · NA · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 150 (estimated)

## Conditions studied

- Resectable Colorectal Carcinoma
- Stage II Colorectal Cancer AJCC v8
- Stage III Colorectal Cancer AJCC v8
- Stage IV Colorectal Cancer AJCC v8

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** cfDNA or ctDNA Measurement
- **OTHER:** Electronic Health Record Review

## Key facts

- **NCT ID:** NCT07125729
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-12
- **Primary completion:** 2028-01-09
- **Final completion:** 2028-01-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07125729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07125729, "Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07125729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*